Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A cold-atom Fermi-Hubbard antiferromagnet.

Mazurenko A, Chiu CS, Ji G, Parsons MF, Kanász-Nagy M, Schmidt R, Grusdt F, Demler E, Greif D, Greiner M.

Nature. 2017 May 24;545(7655):462-466. doi: 10.1038/nature22362.

PMID:
28541324
2.

Site-resolved measurement of the spin-correlation function in the Fermi-Hubbard model.

Parsons MF, Mazurenko A, Chiu CS, Ji G, Greif D, Greiner M.

Science. 2016 Sep 16;353(6305):1253-6. doi: 10.1126/science.aag1430.

3.

Site-resolved imaging of a fermionic Mott insulator.

Greif D, Parsons MF, Mazurenko A, Chiu CS, Blatt S, Huber F, Ji G, Greiner M.

Science. 2016 Feb 26;351(6276):953-7. doi: 10.1126/science.aad9041.

4.

Site-resolved imaging of fermionic ^{6}Li in an optical lattice.

Parsons MF, Huber F, Mazurenko A, Chiu CS, Setiawan W, Wooley-Brown K, Blatt S, Greiner M.

Phys Rev Lett. 2015 May 29;114(21):213002. Epub 2015 May 28.

PMID:
26066433
5.

Order of magnitude smaller limit on the electric dipole moment of the electron.

ACME Collaboration, Baron J, Campbell WC, DeMille D, Doyle JM, Gabrielse G, Gurevich YV, Hess PW, Hutzler NR, Kirilov E, Kozyryev I, O'Leary BR, Panda CD, Parsons MF, Petrik ES, Spaun B, Vutha AC, West AD.

Science. 2014 Jan 17;343(6168):269-72. doi: 10.1126/science.1248213. Epub 2013 Dec 19.

PMID:
24356114
6.

A traveling wave decelerator for neutral polar molecules.

Meek SA, Parsons MF, Heyne G, Platschkowski V, Haak H, Meijer G, Osterwalder A.

Rev Sci Instrum. 2011 Sep;82(9):093108. doi: 10.1063/1.3640413.

PMID:
21974574
7.

A cryogenic beam of refractory, chemically reactive molecules with expansion cooling.

Hutzler NR, Parsons MF, Gurevich YV, Hess PW, Petrik E, Spaun B, Vutha AC, DeMille D, Gabrielse G, Doyle JM.

Phys Chem Chem Phys. 2011 Nov 14;13(42):18976-85. doi: 10.1039/c1cp20901a. Epub 2011 Jun 22.

PMID:
21698321
8.

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.

Parsons MF, Foster PA, Chander SK, Jhalli R, Newman SP, Leese MP, Potter BV, Purohit A, Reed MJ.

Br J Cancer. 2008 Nov 4;99(9):1433-41. doi: 10.1038/sj.bjc.6604707. Epub 2008 Oct 7.

9.

Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.

Purohit A, Chander SK, Woo LW, Parsons MF, Jhalli R, Potter BV, Reed MJ.

Anticancer Res. 2008 May-Jun;28(3A):1517-23.

10.

17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.

Day JM, Foster PA, Tutill HJ, Parsons MF, Newman SP, Chander SK, Allan GM, Lawrence HR, Vicker N, Potter BV, Reed MJ, Purohit A.

Int J Cancer. 2008 May 1;122(9):1931-40. doi: 10.1002/ijc.23350.

11.

Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.

Foster PA, Chander SK, Parsons MF, Newman SP, Woo LW, Potter BV, Reed MJ, Purohit A.

Breast Cancer Res Treat. 2008 Sep;111(1):129-38. Epub 2007 Oct 4.

PMID:
17914670
12.

Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase.

Raobaikady B, Parsons MF, Reed MJ, Purohit A.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):154-60. Epub 2007 Mar 24.

PMID:
17467267
13.

Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative.

Raobaikady B, Parsons MF, Reed MJ, Purohit A.

Steroids. 2006 Jul;71(7):639-46. Epub 2006 May 18.

PMID:
16712888
14.

The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.

Newman SP, Ireson CR, Tutill HJ, Day JM, Parsons MF, Leese MP, Potter BV, Reed MJ, Purohit A.

Cancer Res. 2006 Jan 1;66(1):324-30.

15.

Suppression of myelopoiesis and myeloid leukemia cell line proliferation by a novel bone marrow-derived factor, reptimed.

DeKoter RP, Parsons MF, Fong WG, Lin CH, Khalil W, Howson-Jan K, Singhal SK.

Cell Immunol. 1997 Feb 1;175(2):120-7.

PMID:
9023417
16.
17.

Direct selection in vitro for herbicide-resistant mutants of Nicotiana tabacum.

Chaleff RS, Parsons MF.

Proc Natl Acad Sci U S A. 1978 Oct;75(10):5104-7.

18.

Isolation of a Glycerol-Utilizing Mutant of NICOTIANA TABACUM.

Chaleff RS, Parsons MF.

Genetics. 1978 Aug;89(4):723-8.

19.

The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.

Blackwell GJ, Duncombe WG, Flower RJ, Parsons MF, Vane JR.

Br J Pharmacol. 1977 Feb;59(2):353-66.

20.

Factors influencing the turnover of prostaglandin synthetase.

Blackwell GJ, Flower RJ, Parsons MF, Vane JR.

Br J Pharmacol. 1975 Mar;53(3):467P-468P. No abstract available.

21.

Letter: Reduction of the inflammatory response in rats immunized against prostaglandins.

Ferreira SH, Flower RJ, Parsons MF, Vane JR.

Prostaglandins. 1974 Dec 10;8(5):433-7. No abstract available.

PMID:
4453628

Supplemental Content

Loading ...
Support Center